|
Platelet function inhibitors
Citations 11-20 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Editorials
Antiplatelet Polypharmacy in Primary Percutaneous Coronary Intervention: Trying to Understand When More Is Better
- Ahmed Abdel-Latif and David J. Moliterno
Circulation 2009;119:3168-3170; published online before print as doi:10.1161/CIRCULATIONAHA.109.874552
[Full text]
- Interventional Cardiology
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Kang-Yin Chen, Seung-Woon Rha, Yong-Jian Li, Kanhaiya L. Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, Young Keun Ahn, Taek Jong Hong, Young Jo Kim, Seung Ho Hur, In Whan Seong, Jei Keon Chae, Myeong Chan Cho, Jang Ho Bae, Dong Hoon Choi, Yang Soo Jang, In Ho Chae, Chong Jin Kim, Jung Han Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park for the Korea Acute Myocardial Infarction Registry Investigators
Circulation 2009;119:3207-3214; published online before print as doi:10.1161/CIRCULATIONAHA.108.822791
[Abstract]
[Full text]
- Correspondence
Letter by Cattaneo Regarding Article, "Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk"
- Marco Cattaneo
Circulation 2009;119:e594, doi:10.1161/CIRCULATIONAHA.108.838888
[Full text]
- Articles
Antiplatelet Polypharmacy in Primary Percutaneous Coronary Intervention. Trying to Understand When More Is Better
- Ahmed Abdel-Latif and David J. Moliterno
Circulation published June 15, 2009, doi:10.1161/CIRCULATIONAHA.109.874552
[Abstract]
- Articles
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Kang-Yin Chen, Seung-Woon Rha, Yong-Jian Li, Kanhaiya L. Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, Young Keun Ahn, Taek Jong Hong, Young Jo Kim, Seung Ho Hur, In Whan Seong, Jei Keon Chae, Myeong Chan Cho, Jang Ho Bae, Dong Hoon Choi, Yang Soo Jang, In Ho Chae, Chong Jin Kim, Jung Han Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park for the Korea Acute Myocardial Infarction Registry Investigators
Circulation published June 15, 2009, doi:10.1161/CIRCULATIONAHA.108.822791
[Abstract]
- Coronary Heart Disease
Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38: An Application of the Classification System From the Universal Definition of Myocardial Infarction
- David A. Morrow, Stephen D. Wiviott, Harvey D. White, Jose C. Nicolau, Ezio Bramucci, Sabina A. Murphy, Marc P. Bonaca, Christian T. Ruff, Benjamin M. Scirica, Carolyn H. McCabe, Elliott M. Antman, and Eugene Braunwald
Circulation 2009;119:2758-2764; published online before print as doi:10.1161/CIRCULATIONAHA.108.833665
[Abstract]
[Full text]
- Clinician Update
Can We Override Clopidogrel Resistance?
- Ana Pena, Jean-Philippe Collet, Jean-Sébastien Hulot, Johanne Silvain, Olivier Barthélémy, Farzin Beygui, Christian Funck-Brentano, and Gilles Montalescot
Circulation 2009;119:2854-2857, doi:10.1161/CIRCULATIONAHA.108.857722
[Full text]
- Genetics
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
- Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, Richard D. Hockett, John T. Brandt, Joseph R. Walker, Elliott M. Antman, William L. Macias, Eugene Braunwald, and Marc S. Sabatine
Circulation 2009;119:2553-2560; published online before print as doi:10.1161/CIRCULATIONAHA.109.851949
[Abstract]
[Full text]
- New Drugs and Technologies
Bedside Evaluation of Thienopyridine Antiplatelet Therapy
- Matthew J. Price
Circulation 2009;119:2625-2632, doi:10.1161/CIRCULATIONAHA.107.696732
[Full text]
- Articles
Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38. An Application of the Classification System From the Universal Definition of Myocardial Infarction
- David A. Morrow, Stephen D. Wiviott, Harvey D. White, Jose C. Nicolau, Ezio Bramucci, Sabina A. Murphy, Marc P. Bonaca, Christian T. Ruff, Benjamin M. Scirica, Carolyn H. McCabe, Elliott M. Antman, and Eugene Braunwald
Circulation published May 18, 2009, doi:10.1161/CIRCULATIONAHA.108.833665
[Abstract]
|
|
